Immunotherapeutics for nosocomial infections

Bibliography

• HALL M, LAWRENCE L: Ambulatory surgery in the United States (1996). Advance data from vital and health statistics. In: National Center for Health Statistics (Volume 300). Hyattsville, MD (1998).
   Google Scholar
• HORAN TC, CULVER DH, GAYNES RP, JARVIS WR, EDWARDS JR, REID CR: Nosocomial infections in surgical patients in the United States, January 1986 - June 1992. National Nosocomial Infections Surveillance (NNIS) System. Infect. Control Hosp. Epidemiol. (1993) 14(2):73–80.
   PubMed Web of Science ®Google Scholar
• BOYCE JM, POTTER-BYNOE G, DZIOBEK L: Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp. Epidennol (1990) 11(2):89–93.
   PubMed Web of Science ®Google Scholar
• BOYCE JM, DZIOBEK L, POTTER-BYNOE G: Reimbursement for nosocomial infections. Ann. Intern. Med. (1988) 108(5):776.
   PubMed Web of Science ®Google Scholar
• KIRKLAND KB, BRIGGS JP, TRIVETTE SL, WILKINSON WE, SEXTON DJ: The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect. Control Hosp. Epidemiol (1999) 20(11):725–730.
   PubMed Web of Science ®Google Scholar
• WHITEHOUSE JD, FRIEDMAN ND, KIRKLAND KB, RICHARDSON WJ, SEXTON DJ: The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect. Control Hosp. Epidemiol (2002) 23(4):183–189.
   PubMed Web of Science ®Google Scholar
• •Clinical case study illustrating the profound impact of postsurgical infections.
   Google Scholar
• CDC: National nosocomial infections surveillance (NNIS) system report, data summary from January 1990 - May (1999) Issued June 1999. Am. Infect. Control (1999) 27:520–532.
   PubMed Web of Science ®Google Scholar
• RICHARDS M, EDWARDS J, CULVER D, GAYNES R: Nosocomial infections in medical intensive care units in the United States. Grit. Care Med. (1999) 27:887–892.
   PubMed Web of Science ®Google Scholar
• DUCKWORTH DH, GULIG PA: Bacteriophages: potential treatment for bacterial infections. BioDrugs (2002) 16(1):57–62.
   PubMed Web of Science ®Google Scholar
• DONABEDIAN H: Quorum sensing and its relevance to infectious diseases.' Infect. Dis. (2003) 46(4):207–214.
   Google Scholar
• VON EIFF C, KOKAI-KUN JF, BECKER K, PETERS G: In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood. Antimicrob. Agents Chemother. (2003) 47(11):3613–3615.
   PubMed Web of Science ®Google Scholar
• WU JA, KUSUMA C, MOND JJ, KOKAI-KUN JF: Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob. Agents Chemother. (2003) 47(11):3407–3414.
   PubMed Web of Science ®Google Scholar
• RICHARDS MJ, EDWARDS JR, CULVER DH, GAYNES RP: Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. (1999) 27(5):887–892.
   Google Scholar
• MORIN CA, HADLER JL: Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. Infect. Dis. (2001) 184(8):1029–1034.
   Google Scholar
• CHANG S, SIEVERT DM, HAGEMAN JC et al.: Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl.' Med. (2003) 348(14):1342–1347.
   PubMed Web of Science ®Google Scholar
• •Details of a VRSA isolated from an infected patient.
   Google Scholar
• Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb. Mortal. Wkly Rep. (2002) 51(26):565–567.
   PubMedGoogle Scholar
• LEE JC: Staphylococcus aureus vaccine. In: New Bacteria] Vaccines. Ellis R, Brodeur B (Eds), Kluwer Academic/Plenum (2003):283–293.
   Google Scholar
• ••Excellent review of potential S. aureusvaccines.
   Google Scholar
• LEE J: Development of antistaphylococcalvaccines. Carr. Infect. Dis. Rep. (2001) 3:517–524.
   PubMedGoogle Scholar
• PATTI JM, ALLEN BL, MCGAVIN MJ,HOOK M: MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev Microbial. (1994) 48:585–617.
   PubMed Web of Science ®Google Scholar
• •Description of MSCRAMM proteins.
   Google Scholar
• FOSTER TJ, HOOK M: Surface protein adhesins of Staphylococcus aureus. Trends Microbic] (1998) 6(12):484–488.
   PubMed Web of Science ®Google Scholar
• McDEVITT D, FRANCOIS P, VAUDAUX P, FOSTER TJ: Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Ma Micro. (1994) 11(2):237–248.
   Google Scholar
• McDEVITT D, VAUDAUX P, FOSTER TJ: Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect. Immun. (1992) 60(4):1514–1523.
   PubMed Web of Science ®Google Scholar
• SIBOO IR, CHEUNG AL, BAYER AS, SULLAM PM: Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect. Inman. (2001) 69(5):3120–3127.
   PubMed Web of Science ®Google Scholar
• MOREILLON P, ENTENZA JM, FRANCIOLI P et al: Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Inman. (1995) 63(12):4738–4743.
   PubMed Web of Science ®Google Scholar
• QUE YA, HAEFLIGER JA, FRANCIOLI P, MOREILLON P: Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect. Inman. (2000) 68(6):3516–3522.
   PubMed Web of Science ®Google Scholar
• STUTZMANN MEIER P, ENTENZA JM, VAUDAUX P, FRANCIOLI P, GLAUSER MP, MOREILLON P: Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii. Infect. Inman. (2001) 69(2):657–664.
   PubMed Web of Science ®Google Scholar
• WOLZ C, GOERKE C, LANDMANN R, ZIMMERLI W, FLUCKIGER U: Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection. Infect. Inman. (2002) 70(6):2758–2762.
   PubMed Web of Science ®Google Scholar
• COLQUE-NAVARRO P, PALMA M, SODERQUIST B, FLOCK JI, MOLLBY R: Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin. Diagn. Lab. Immunol (2000) 7(1):14–20.
   PubMedGoogle Scholar
• VERNACHIO J, BAYER A, LET et al.: Anti-clumping factor a immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob. Agents Chemother. (2003) 47(11):3400–3406.
   PubMed Web of Science ®Google Scholar
• HALL A, DOMANSKI P, PATEL P et al.: Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect. Inman. (2003) 71(12):6864–6870.
   PubMed Web of Science ®Google Scholar
• •Description of a mAb targeting S. aureus.
   Google Scholar
• McCREA KW, HARTFORD 0, DAVIS S et al: The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. Microbiology (2000) 146 (Pt. 7):1535–1546.
   PubMedGoogle Scholar
• •First description of Sdr family proteins found in a bacterium other than S. aureus.
   Google Scholar
• STOLL BJ, HANSEN N, FANAROFF AA et al.: Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics (2002) 110(2 Pt. 1):285–291.
   Google Scholar
• ••Important demographics and statistics ofinfection in premature babies.
   Google Scholar
• BLOOM B, KUESER T, OELBERG D et al.: A Phase I, multicenter study and tolerance of a donor-selected staphylococcal immune globulin in very low birth weight infants. Pediatric Academic Societies Annual Meeting, Seattle, Washington (2003).
   Google Scholar
• LESINSKI GB, WESTERINK MA: Vaccints against polysaccharide antigens. Curt: Drug. Targets Infect. Disord. (2001) 1(3):325–334.
   PubMedGoogle Scholar
• THAKKER M, PARK JS, CAREY V, LEE JC: Staphylococcus aureusserotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect. Immun. (1998) 66(11):5183–5189.
   PubMed Web of Science ®Google Scholar
• ADDERSON EE: Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations. Springer Semin. Immunopathol (2001) 23(4):387–403.
   PubMed Web of Science ®Google Scholar
• ANTTILA M, VOUTILAINEN M, JANTTI V, ESKOLA J, KAYHTY H: Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae. Clin. Exp. Immunol (1999) 118(3):402–407.
   PubMed Web of Science ®Google Scholar
• FATTOM Al, SARWARJ, ORTIZ A, NASO R: A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect. Immun. (1996) 64(5):1659–1665.
   PubMed Web of Science ®Google Scholar
• •Report of efficacy in a mouse intraperitoneal challenge model with a S. aureus capsular polysaccharide vaccine.
   Google Scholar
• LEE J, PARK J, SHEPHERD S: Protective efficacy of antibodies to the Staphylococcus am-vas Type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect. Immun. (1997) 65:4146–4151.
   PubMed Web of Science ®Google Scholar
• NEMETH J, LEE JC: Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis. Infect. Immun. (1995) 63(2):375–380.
   PubMed Web of Science ®Google Scholar
• WELCH PG, FATTOM A, MOORE J et al.: Safety and immunogenicity of Staphylococcus aureus Type 5 capsular polysaccharide-pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. Amer. Soc. Nephrol. (1996) 7(2):247–253.
   PubMed Web of Science ®Google Scholar
• SHINEFIELD H, BLACK S, FATTOM A et al.: Use of a Staphylococcus am-vas conjugate vaccine in patients receiving hemodialysis. N Eng. .1. Med. (2002) 346(7):491–496.
   Google Scholar
• ••Phase III data on StaphvAr.
   Google Scholar
• SCHMITT L, TAMPE R: Structure and mechanism of ABC transporters. Curr. Opin. Struct. Biol. (2002) 12:754–760.
   PubMed Web of Science ®Google Scholar
• HIGGENS C: ABC transporters: from microorganisms to man. Anna. Rev Cell Biol. (1992) 8:67–113.
   Web of Science ®Google Scholar
• BURNIE JP, MATTHEWS RC, CARTER T et al.: Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect. Immun. (2000) 68(6):3200–3209.
   PubMed Web of Science ®Google Scholar
• FISCHER W: Physiology of lipoteichoic acid in bacteria. Adv. Microb. Physiol (1988) 29:233–302.
   PubMed Web of Science ®Google Scholar
• GAO J, XUE E, ZUVANICH K, HAGHI K, MORRISON D: Commercial preparations of lipoteichoic acid contain endotwdn that contributes to activation of mouse macrophages in vitro. Infect. Immun. (2001) 69:751–757.
   PubMed Web of Science ®Google Scholar
• ELLINGSEN E, MORATH S, FLO T et al.: Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med. Set. Monit. (2002) 8(5):BR149-BR156.
   Google Scholar
• DE KIMPE SJ, KENGATHARAN M, THIEMERMANN C, VANE JR: The cell wall components peptidoglycan and lipoteichoic acid from staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl Acad. Set. USA (1995) 92(22):10359–10363.
   PubMed Web of Science ®Google Scholar
• KENGATHARAN KM, DE KIMPE S, ROBSON C, FOSTER SJ, THIEMERMANN C: Mechanism of Gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. I Exp. Med. (1998) 188(2):305–315.
   PubMed Web of Science ®Google Scholar
• WEISMAN L, MANDY G, GARCIA-PRATS J et al.: Safety and pharmockinetics of a human chimeric-anti staphylococcal monoclonal antibody for prevention of coagulase negative staphylococcal infection in very low birth weight infants: preliminary report. Pediatric Academic Societies Annual Meeting, Seattle, Washington (2003).
   Google Scholar